Protective Effect of Qiliqiangxin against Doxorubicin-Induced Cardiomyopathy by Suppressing Excessive Autophagy and Apoptosis

Background. Doxorubicin (DOX) is one of the most potent and widely prescribed antitumor agents; however, its clinical use is limited by cardiac side effects. In this study, we aimed to clarify the protective effects of Qiliqiangxin (QL), a traditional Chinese medicine formulation, on DOX-induced car...

Full description

Saved in:
Bibliographic Details
Main Authors: Yating Qin (Author), Chao Lv (Author), Xinxin Zhang (Author), Weibin Ruan (Author), Xiangyu Xu (Author), Chen Chen (Author), Xiaoning Wan (Author), Xinyun Ji (Author), Juan Zhou (Author), Li Lu (Author), Xiaomei Guo (Author)
Format: Book
Published: Hindawi-Wiley, 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_fec5e51e6f3b4c29b0640265c8f6fd5a
042 |a dc 
100 1 0 |a Yating Qin  |e author 
700 1 0 |a Chao Lv  |e author 
700 1 0 |a Xinxin Zhang  |e author 
700 1 0 |a Weibin Ruan  |e author 
700 1 0 |a Xiangyu Xu  |e author 
700 1 0 |a Chen Chen  |e author 
700 1 0 |a Xiaoning Wan  |e author 
700 1 0 |a Xinyun Ji  |e author 
700 1 0 |a Juan Zhou  |e author 
700 1 0 |a Li Lu  |e author 
700 1 0 |a Xiaomei Guo  |e author 
245 0 0 |a Protective Effect of Qiliqiangxin against Doxorubicin-Induced Cardiomyopathy by Suppressing Excessive Autophagy and Apoptosis 
260 |b Hindawi-Wiley,   |c 2022-01-01T00:00:00Z. 
500 |a 1755-5922 
500 |a 10.1155/2022/9926635 
520 |a Background. Doxorubicin (DOX) is one of the most potent and widely prescribed antitumor agents; however, its clinical use is limited by cardiac side effects. In this study, we aimed to clarify the protective effects of Qiliqiangxin (QL), a traditional Chinese medicine formulation, on DOX-induced cardiotoxicity and to explore the underlying mechanisms in a rat model. Methods. Male Sprague-Dawley rats were randomly assigned to three groups with different interventions (control, DOX, and DOX plus QL) for 31 days. Cardiac function was monitored. The levels of oxidative stress in plasm were detected, the activities of autophagy and apoptosis in rat hearts were determined, and then, the related PI3K/AKT/mTOR signal pathway regulating apoptosis and autophagy was investigated. Results. QL improved cardiac dysfunction and decreased the increased level of cardiac enzymes in plasm caused by DOX. Moreover, DOX exposure resulted in oxidative stress enhancement, which was suppressed by QL treatment. Then, we discovered that DOX intervention caused the apoptosis of cardiomyocytes by activating the mitochondrial-dependent apoptotic pathway which was strongly inhibited by QL treatment. Furthermore, there was a significant increase in autophagic activities in the DOX-stimulated myocardium. Administration of QL substantially inhibited the enhanced autophagic activities, which might be attributed to the activation of PI3K/AKT/mTOR cascade, followed by suppression of ULK1 activity. Conclusions. QL exhibited protective roles against DOX-induced cardiotoxicity possibly via mediating the PI3K/AKT/mTOR pathway, leading to inhibition of autophagy and subsequent apoptosis activities. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Diseases of the circulatory (Cardiovascular) system 
690 |a RC666-701 
655 7 |a article  |2 local 
786 0 |n Cardiovascular Therapeutics, Vol 2022 (2022) 
787 0 |n http://dx.doi.org/10.1155/2022/9926635 
787 0 |n https://doaj.org/toc/1755-5922 
856 4 1 |u https://doaj.org/article/fec5e51e6f3b4c29b0640265c8f6fd5a  |z Connect to this object online.